Skip to main content
. 2019 May 17;3(3):372–382. doi: 10.1002/rth2.12205

Table 2.

Characteristics of children with CPHD (N = 120 884) with and without VTE in the MarketScan Commercial Databases for 2003‐2013

VTE (n = 957) n (%) No VTE (n = 119 927) n (%) P value
Age (y)
<1 501 (52.4) 52 969 (44.2) <0.0001
1‐4 58 (6.1) 12 134 (10.1)
5‐9 43 (4.5) 15 364 (12.8)
10‐14 123 (12.9) 21 380 (17.8)
15‐17 232 (24.2) 18 080 (15.1)
Mean age (SD) 6.0 (7.1) 5.7 (6.3) 0.27
Male gender 582 (60.8) 62 918 (52.5) <0.0001
Type of CPHDa
Single‐ventricle physiology 262 (27.4) 11 186 (9.3) <0.0001
Two‐ventricle physiology 364 (38.0) 71 836 (59.9) <0.0001
Cardiomyopathies 37 (3.9) 2255 (1.9) <0.0001
Conduction disorders and dysrhythmias 291 (30.4) 34 090 (28.4) 0.18
Acquired chronic cardiovascular conditions 101 (10.6) 5411 (4.5) <0.0001
In‐hospital mortality 103 (10.8) 1582 (1.3) <0.0001
Co‐occurring conditions and procedures
Noncardiac complex chronic conditions 618 (64.6) 25 815 (21.5) <0.0001
Neuromuscular 242 (25.3) 7093 (5.9) <0.0001
Respiratory 165 (17.2) 5398 (4.5) <0.0001
Renal 84 (8.8) 2207 (1.8) <0.0001
Gastrointestinal 79 (8.3) 2032 (1.7) <0.0001
Hematology and immunodeficiency 77 (8.1) 1699 (1.4) <0.0001
Metabolic 93 (9.7) 2297 (1.9) <0.0001
Other congenital or genetic defect 220 (23.0) 10 183 (8.5) <0.0001
Malignancy 153 (16.0) 3621 (3.0) <0.0001
Recent trauma 182 (19.0) 6502 (5.4) <0.0001
Recent infection 370 (38.7) 9725 (8.1) <0.0001
Recent noncardiac surgery 478 (50.0) 5663 (4.7) <0.0001
Recent cardiac surgery 511 (53.4) 4106 (3.4) <0.0001
Acquired acute cardiovascular conditions 123 (12.9) 1724 (1.4) <0.0001
Evidence of end‐stage cardiac disease
Heart transplantation 4 (0.4) 1 (0.0) <0.0001
Extracorporeal membranous oxygenation 22 (2.3) 83 (0.07) <0.0001

CPHD, chronic pediatric heart disease; SD, standard deviation; VTE, venous thromboembolism.

a

Categories not mutually exclusive.